Post-earnings recap
Reported
Thu, Jan 31, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
This earnings report indicates that while Edwards Lifesciences missed EPS expectations slightly, the stock reacted positively, gaining 1%. The increase may reflect investor confidence in the company's product demand despite market challenges. The lack of guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.17 | N/A | -2.90% |
Overall, management conveyed a sense of cautious optimism about the future. They acknowledged current market challenges but emphasized strong product demand.
Management highlighted ongoing demand for their heart valve products.
They noted challenges in the market but expressed confidence in long-term growth.